These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 576150)

  • 41. [Use of Le Veen's valve in the treatment of cirrhotic ascites (author's transl)].
    Bourgeon R; Isman H; Brisard M; Dragacci JJ
    Chirurgie; 1979; 105(3):241-51. PubMed ID: 467166
    [No Abstract]   [Full Text] [Related]  

  • 42. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
    Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
    N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Operative details of continuous peritoneo-venous shunt for ascities.
    Le veen HH; Wapnick S
    Bull Soc Int Chir; 1975; 34(6):579-82. PubMed ID: 1233115
    [No Abstract]   [Full Text] [Related]  

  • 44. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function.
    Somberg KA; Lake JR; Tomlanovich SJ; LaBerge JM; Feldstein V; Bass NM
    Hepatology; 1995 Mar; 21(3):709-16. PubMed ID: 7875668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Operative assessment of peritoneal-venous (Leveen) shunt catheter tip location.
    Swan KG; Rocko JM; Timmes JJ; Howard MM
    Am Surg; 1980 Mar; 46(3):171-3. PubMed ID: 7377661
    [No Abstract]   [Full Text] [Related]  

  • 47. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.
    Nguyen-Khac E; Thevenot T; Capron D; Dharancy S; Paupart T; Thabut D; Tiry C
    Eur J Intern Med; 2008 Dec; 19(8):613-8. PubMed ID: 19046728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The effect of shunting of the thoracic duct and the jugular vein in patients with ascitic liver cirrhosis].
    Serényi P; Szabó G; Magyar Z
    Orv Hetil; 1970 Mar; 111(10):564-5. PubMed ID: 5436291
    [No Abstract]   [Full Text] [Related]  

  • 49. [Surgical approach to posthepatitic cirrhotic patient today].
    Meriggi F; Forni E
    G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ascites, the LeVeen shunt, and endotoxin.
    Buhac I
    Ann Intern Med; 1980 Apr; 92(4):572. PubMed ID: 7362172
    [No Abstract]   [Full Text] [Related]  

  • 51. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity.
    Levy M; Wexler MJ
    J Lab Clin Med; 1978 Mar; 91(3):520-36. PubMed ID: 627753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Refractory ascites in cirrhosis.
    Levinsky NG
    Kidney Int; 1978 Jul; 14(1):93-102. PubMed ID: 682430
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of irreducible ascites of cirrhotic patients with peritoneo-jugular shunt].
    Capussotti L; Aricò S; Marucci M; Dellepiane M; De La Pierre M
    Minerva Med; 1982 Dec; 73(49-50):3477-84. PubMed ID: 7155396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F; Raina N; Richardson R
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Abdominal indwelling central venous catheter in treatment of liver fibrosis and intractable ascites].
    Zhang HX; Li J; Cheng C
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Aug; 25(4):427, 430. PubMed ID: 24358760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of refractory ascites by means of the LeVeen shunt].
    Gonvers JJ; Loup P; Brunner HR; Mosimann R; Hofstetter JR
    Schweiz Med Wochenschr; 1981 Feb; 111(7):220-3. PubMed ID: 7013063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effectiveness of the Le Veen valve in the cure of ascites after the concentration-reinfusion treatment of the ascitic fluid].
    Torre GC; Binda GA; Testa R; Iachino G; Mattioli F
    Minerva Med; 1980 Mar; 71(9):627-30. PubMed ID: 7360398
    [No Abstract]   [Full Text] [Related]  

  • 58. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.
    Guevara M; Ginès P; Bandi JC; Gilabert R; Sort P; Jiménez W; Garcia-Pagan JC; Bosch J; Arroyo V; Rodés J
    Hepatology; 1998 Aug; 28(2):416-22. PubMed ID: 9696006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New therapeutic possibility in the treatment of ascites refractory to medical treatment].
    Rovati V; Cavagna G; Toti GL; Salati M
    Minerva Med; 1980 Mar; 71(9):631-3. PubMed ID: 7360399
    [No Abstract]   [Full Text] [Related]  

  • 60. Modified saphenous-peritoneal shunt in refractory ascites: new technique.
    Chen JH; Liu HD; Yu JC; Chen CJ; Shih ML; Liu YC; Hsieh CB
    ANZ J Surg; 2005 Mar; 75(3):128-31. PubMed ID: 15777390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.